StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
2302.HK$4.60+9.00%
Fair $4.60+0.0%

2302.HK

CNNC International Limited

Energy / UraniumHKSE

$4.60

+0.38 (+9.00%)

Fairly Valued+0.0%Fair Value $4.60Fund rank 33/100 · Data gapFallback financials|
SA 64/B
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $139.3M · quality 67.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 54/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

64/100

B

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 2302.HKLocal privado en este navegador · CNNC International Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.3B

P/E

11.8x

↓

EV/EBITDA

5.8x

↓

ROE

22.1%

↑

Gross Margin

10.9%

↓

Debt/Equity

0.00

↓
52-Week Range$5
$2$9

TradingView lightweight chart

2302.HK price, volumen y niveles de valoración

Último $4.600Periodo +369.4%
Fair value: $4.600

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+40.1%

FCF CAGR

+241.1%

FCF margin

11.5%

FCF / Net income

1.49x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.49B · net income $192.4M · FCF $287.4M

2022-FY → 2025-FY

Gross margin

10.9%-0.4% pts

Operating margin

8.9%+1.2% pts

Net margin

7.7%-1.2% pts

FCF margin

11.5%+10.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.49B$2.49B$1.84B$581.0M$905.7M
Net Income$192.4M$192.4M$195.0M$106.3M$80.8M
EBITDA$232.3M$232.3M$250.1M$137.4M$96.9M
EPS0.390.390.400.220.17
Gross Margin10.9%10.9%12.7%21.9%11.3%
Operating Margin8.9%8.9%10.0%16.2%7.7%
Net Margin7.7%7.7%10.6%18.3%8.9%
Balance Sheet
Debt/Equity0.000.000.000.410.56
Current Ratio7.777.77———
Cash Flow
Free Cash Flow$287.4M$287.4M$139.3M$72.9M$7.2M
Returns
ROE22.1%22.1%28.9%23.1%20.6%
Valuation
P/E11.7911.794.097.9312.12
EV/EBITDA5.795.790.776.1711.00
P/B2.592.591.181.832.50
Growth & Yield
Revenue Growth35.2%35.2%217.0%-35.9%—
EPS Growth-1.5%-1.5%83.9%31.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

1.3%

fácil

EPS terminal req.

$0.41

Spread vs growth

-2.8%

5Y implied EPS CAGR

4.7%

fácil

EPS terminal req.

$0.49

Spread vs growth

-6.2%

10Y implied EPS CAGR

7.3%

razonable

EPS terminal req.

$0.80

Spread vs growth

-8.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +158.4%

Total return

+158.4%

Start / end P/E

4.5x → 11.7x

EPS bridge

0.40 → 0.39

Residual

-2.4%

EPS growth-1.5%
Multiple rerating+162.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-2.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.